Zobrazeno 1 - 10
of 94
pro vyhledávání: '"W. Charles O'Neill"'
Autor:
Kum Hyun Han, W. Charles O'Neill
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 1 (2016)
BackgroundMatrix Gla protein is a vitamin K–dependent inhibitor of vascular calcification. Warfarin use is associated with increased breast arterial calcification, but whether this is reflective of other arteries or occurs in men is unclear. In thi
Externí odkaz:
https://doaj.org/article/8cdd9b233f724e92b09860a0b8299e72
Autor:
Catherine A. Moore, Daniel W. Ross, Kurtis A. Pivert, Valerie J. Lang, Stephen M. Sozio, W. Charles O’Neill
Publikováno v:
Clinical Journal of the American Society of Nephrology. 17:1487-1494
Point-of-care ultrasound (POCUS)-performed by a clinician during a patient encounter and used in patient assessment and care planning-has many potential applications in nephrology. Yet, US nephrologists have been slow to adopt POCUS, which may affect
Autor:
W. Charles O'Neill
Publikováno v:
Seminars in dialysisREFERENCES.
Publikováno v:
Kidney International Reports
Introduction Medial arterial calcification is a common and progressive lesion in end-stage renal disease that is associated with poor cardiovascular outcomes. Whether this lesion can be arrested or reversed is unknown, and was examined retrospectivel
Publikováno v:
Seminars in dialysisREFERENCES.
Hemodialysis solutions typically contain a high alkali concentration designed to counter interdialytic acidosis, but this could result in persistent alkalosis in some patients. The prevalence and significance of persistent alkalosis were therefore ex
Autor:
W Charles, O'Neill
Publikováno v:
Journal of the American Society of Nephrology. 33:1627-1627
Autor:
Joe R. Nocera, W. Charles O'Neill, Ihab Hajjar, Justin D. Sprick, James L. Bailey, Jeanie Park
Publikováno v:
Am J Physiol Renal Physiol
Patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) experience an increased risk of cerebrovascular disease and cognitive dysfunction. Hemodialysis (HD), a major modality of renal replacement therapy in ESKD, can cause rapi
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 40(5)
Objective: Warfarin is associated with medial arterial calcification in humans, but the magnitude and specificity of this effect and the role of other risk factors are unknown. Using serial mammograms, progression of arterial calcification was compar
Autor:
Ioannis Sechopoulos, Ansley O’Neill, W. Charles O'Neill, Kum Hyun Han, Arshad Ali, Baowei Fei, Shumila Manzoor, Syed Ahmed
Publikováno v:
Kidney International Reports
Kidney International Reports, 3, 1328-1335
Kidney International Reports, 3, 6, pp. 1328-1335
Kidney International Reports, 3, 1328-1335
Kidney International Reports, 3, 6, pp. 1328-1335
Contains fulltext : 200345.pdf (Publisher’s version ) (Open Access) Introduction: Medial arterial calcification is common in chronic kidney disease (CKD) and portends poor clinical outcomes, but its progression relative to the severity of CKD and t